The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Avania expands European presence with acquisition of Spanish CRO Anagram
Avania has expanded its European presence by acquiring Spanish medtech CRO Anagram, enhancing its capabilities in cardiology, oncology, and neurology. This strategic move aims to eliminate reliance on outsourcing partners and provide Avania's clients with a broader geographic reach and specialized expertise. The acquisition aligns with Avania's vision of becoming a trusted global partner in advancing medical technology and improving patient outcomes.
Avania expands European presence with acquisition of Spanish CRO Anagram
Avania has acquired Anagram, a leading Spanish medical technology CRO based in Barcelona, to enhance its CRO offerings in Southern Europe. Founded in 1998, Anagram specializes in cardiology, oncology, and neurology, providing comprehensive clinical development services. This acquisition will expand Avania's geographic reach and expertise, benefiting its clients with increased resources and capabilities in the MedTech sector.
Avania expands European presence with acquisition of Spanish CRO Anagram
Avania has acquired Spanish medical technology CRO Anagram to enhance its presence in Southern Europe and expand its CRO offerings. Anagram, based in Barcelona, specializes in cardiology, oncology, and neurology, providing comprehensive clinical development services. This acquisition will strengthen Avania's capabilities and foster cross-selling opportunities in the growing MedTech market.